Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Marín-Jiménez JA; García-Mulero S; Matías-Guiu X; Piulats JM

    Facts and hopes in immunotherapy of endometrial cancer.

    CLINICAL CANCER RESEARCH 28 4849-4860. .

    [doi:10.1158/1078-0432.CCR-21-1564]

  • Barceló C; Sisó P; de la Rosa I; Megino-Luque C; Navaridas R; Maiques O; Urdanibia I; Eritja N; Soria X; Potrony M; Calbet-Llopart N; Puig S; Matías-Guiu X; Martí RM; Macià A

    M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.

    BRITISH JOURNAL OF CANCER 127 1142-1152. .

    [doi:10.1038/s41416-022-01886-4]

  • Carretero-Barrio I; Lop-Gros J; Iglesias M; Martínez C; Matias-Guiu X; Pérez-Mies B; Palacios J

    Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents.

    VIRCHOWS ARCHIV 481 1-5. .

    [doi:10.1007/s00428-022-03303-w]

  • Ruiz-Mitjana A; Navaridas R; Vidal-Sabanés M; Perramon-Güell A; Yeramian A; Felip I; Eritja N; Egea J; Encinas M; Matias-Guiu X; Dolcet X

    Lack of extracellular matrix switches TGF-ß induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

    SCIENTIFIC REPORTS 12 14821-14821. .

    [doi:10.1038/s41598-022-18976-1]

  • Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N

    Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

    Cancers 14 -. .

    [doi:10.3390/cancers14122842]

  • Megino-Luque, C; Siso, P; Mota-Martorell, N; Navaridas, R; de la Rosa I; Urdanibia, I; Alberti-Valls, M; Santacana, M; Pinyol, M; Bonifaci, N; Macia, A; Llobet-Navas, D; Gatius, S; Matias-Guiu, X; Eritja, N

    ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

    MOLECULAR ONCOLOGY 16 2235-2259. .

    [doi:10.1002/1878-0261.13193]

  • Jiménez-Sánchez D; Ariz M; Chang H; Matias-Guiu X; de Andrea CE; Ortiz-de-Solórzano C

    NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images.

    MEDICAL IMAGE ANALYSIS 78 102384-102384. .

    [doi:10.1016/j.media.2022.102384]

  • Gatius, S; Velasco, A; Varela, M; Cuatrecasas, M; Jares, P; Setaffy, L; Bonhomme, B; Santon, A; Lindemann, K; Croce, S; Davidson, B; Lax, S; Palacios, J; Matias-Guiu, X

    Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study.

    VIRCHOWS ARCHIV 480 1031-1039. .

    [doi:10.1007/s00428-022-03291-x]

  • Mota, A; Oltra, SS; Selenica, P; Moiola, CP; Casas-Arozamena, C; Lopez-Gil, C; Diaz, E; Gatius, S; Ruiz-Miro, M; Calvo, A; Rojo-Sebastian, A; Hurtado, P; Piñeiro R; Colas, E; Gil-Moreno, A; Reis-Filho, JS; Muinelo-Romay, L; Abal, M; Matias-Guiu, X; Weigelt, B; Moreno-Bueno, G

    Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.

    ONCOGENE 41 1835-1850. .

    [doi:10.1038/s41388-022-02221-0]

  • MATIAS-GUIU GUIA, XAVIER

    Prevención secundaria de cáncer de cuello de útero, 2022. Conducta clínica ante resultados anormales de las pruebas de cribado

    Prevención secundaria del cancer de cuello de útero, 2022. Conducta clínica ante resultados anormales de las pruebas de cribado. -. .

  • MORENO, S; MAIQUES, O; Romero M; Santacana M; Gómez I; Cuevas D; Velasco A; Veà À; Macià A; Barceló C; BOIX, R; VALLS, J; GATIUS, S; CANTI, C; MATIAS-GUIU, X; SORIA, X; MARTI, RM

    Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

    ACTA DERMATO-VENEREOLOGICA 101 -. .

    [doi:10.2340/actadv.v101.361]

  • Rofes P; González S; Navarro M; Moreno-Cabrera JM; Solanes A; Darder E; Carrasco E; Iglesias S; Salinas M; Gómez C; Velasco À; Tuset N; Varela M; Llort G; Ramon Y Cajal T; Grau È; Dueñas N; de la Ossa Merlano N; Matías-Guiu X; Rivera B; Balmaña J; Pineda M; Brunet J; Capellá G; Del Valle J; Lázaro C

    Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis.

    Journal Of Molecular Diagnostics 23 1452-1459. .

    [doi:10.1016/j.jmoldx.2021.07.024]

Projects

  • EPH Receptor Signaling in Endometrial Cancer
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • Alteraciones moleculares relacionados con la progresión tumoral en el cáncer de endometrio